Health Policy
WHO guidelines, EU directives, and Georgian health governance
What EFSA Health Claims Actually Mean for Supplements
"EFSA-authorized claim" is one of the strongest evidence signals on a European supplement label — and one of the most…
Editor's Top Picks
The Georgian Supplement Market: What the Law Requires — and What Compliance Reviews Find
Georgian law aligns supplement rules with the EU framework on paper. PHIG's documentation of the market shows where practice falls…
Submit Your Paper →
More form Health Policy
Regulatory Agencies Split on New Alzheimer’s Drugs as Hope Meets Uncertainty
Regulatory agencies worldwide are delivering conflicting assessments of novel Alzheimer's treatments, creating uncertainty for millions…
Geographic Disparities Persist in US Lung Transplant Access Despite Policy Changes
New research reveals that geographic location continues to influence access to donor lungs in the…
Three-Quarters of High-Burden Countries Could Self-Fund TB Programs Without Donor Support
New research shows 74% of high TB burden countries could self-finance programs through strategic budget…
WHO’s Cancer Medicine Recommendations Lack Economic Evidence for African Countries, Study Finds
WHO's cancer medicine recommendations lack robust economic evidence for African countries, with only 11% including…
Trump Drug Pricing Deals Face First Test as New Medications Launch
President Trump's most-favored-nation drug pricing agreements with 17 pharmaceutical companies face their first real-world test…